What You Should Know:
- McKesson has unveiled the Precision Care Companion (PCC), a transformative initiative designed to tackle the multifaceted challenges that healthcare practices face in the rapidly evolving landscape of genomic testing and targeted therapies.
- The Precision Care Companion is structured as a consortium of leading industry experts, spearheaded by McKesson. This collaborative model is intentionally designed to foster a dynamic environment that unites a diverse
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
Daymark Health Launches with $11.5M to Redefine Cancer Care
What You Should Know:
- Daymark Health, a company aiming to redefine the cancer care experience, has publicly launched with an $11.5M in seed funding co-led by Maverick Ventures and Yosemite, with additional participation from Oncology Ventures. Daymark was launched out of Healthcare Foundry, with Robert Pahlavan and Jonathan Rhodes as co-founders leading thesis development.
- The company began operations this year in partnership with a leading payer in the Northeast, providing
Read More
Flatiron Health, NRG Oncology to Streamline Cancer Clinical Trials with EHR-to-EDC
What You Should Know:
- Flatiron Health, a healthtech company focused on revolutionizing clinical research through technology integration, has announced a collaboration with NRG Oncology, a clinical research consortium within the National Cancer Institute's (NCI) National Clinical Trials Network (NCTN).
- The partnership aims to deploy Flatiron’s Clinical Pipe™ in a multicenter NRG clinical trial, streamlining data entry and accelerating study timelines.
Supporting
Read More
AI Accelerates Cancer Research: ACS Partners with Layer Health for LLM Data Extraction
What You Should Know:
- The American Cancer Society (ACS) and Layer Health, an innovator in AI-driven healthcare technology, have announced a multi-year collaboration aimed at accelerating cancer research. This partnership will leverage large language models (LLMs) to streamline the extraction of vital clinical data from patient medical records.
- This collaboration builds upon a successful pilot program that focused on breast cancer patients. The pilot demonstrated the platform's
Read More
Paige Expands PanCancer Detect to Identify Cancer in Over 40 Tissue Types
What You Should Know:
- Paige, a provider of AI-powered pathology solutions, today announced a significant expansion of Paige PanCancer Detect, its groundbreaking cancer detection tool.
- Originally launched in 2024 with the ability to identify cancer in 17 tissue types, PanCancer Detect now supports over 40 tissue and organ types, thanks to advancements in Paige's AI foundation models.
AI-Powered Pathology Solution Enhances Diagnostic Accuracy and Efficiency
This
Read More
Flatiron Health and Exact Sciences Partner to Accelerate Clinical Evidence Generation for MRD Testing in Oncology
What You Should Know:
- Flatiron Health, a leading technology company focused on improving cancer care announced a strategic partnership with Exact Sciences, a pioneer in cancer screening and diagnostics to accelerate clinical evidence generation for Exact Sciences' molecular residual disease (MRD) test, Oncodetect™.
- The collaboration will leverage Flatiron's innovative clinical research platform and extensive network of community oncology practices to study the test's performance
Read More
Color Health Report Reveals Gaps in Employer Cancer Benefits
What You Should Know:
- Color Health, a provider of precision health solutions released its second annual Employer Insights Report, revealing a disconnect between employer priorities and the reality of cancer care benefits offered to employees.
- The survey, conducted by The Harris Poll, explores how benefits leaders make decisions regarding cancer program benefits, including their current offerings, perceived effectiveness, and strategies for managing costs.
Disconnect
Read More
Oatmeal Health Unveils AI Diagnostic Platform for Lung Cancer Screening in Underserved FQHC Communities
What You Should Know:
- Oatmeal Health, an innovator in AI-driven cancer screening launches its AI-powered radiology risk stratification platform for lung cancer.
- The solution provides a fully reimbursable second-opinion diagnostic tool covered by Medicare, making it more accessible and affordable for healthcare providers and patients.
AI-Powered Lung Nodule Analysis
Lung cancer remains a leading cause of cancer-related deaths worldwide, but screening rates remain
Read More
C the Signs Raises $8M to Expand AI-Powered Cancer Detection to the U.S.
What You Should Know:
- C the Signs, a developer of AI-powered cancer detection solutions, today announced an $8 million funding round led by Khosla Ventures.
- The investment will fuel the company's expansion from the United Kingdom, where it has already achieved significant success in early cancer detection, to the United States.
Cancer Screening and Improve Patient Outcomes
C the Signs addresses a critical gap in cancer care by identifying patients at risk of cancer at
Read More
Guardant Health and ConcertAI Partner to Unlock Cancer Insights with Multi-Modal Real-World Data
What You Should Know:
- Guardant Health, a provider in precision oncology, and ConcertAI, a real-world evidence (RWE) and AI technology company in oncology, announced a strategic collaboration that will provide biopharmaceutical companies with access to a first-of-its-kind multi-modal real-world data (RWD) solution.
- The partnership integrates comprehensive patient electronic medical record (EMR) data with genomic and epigenomic tumor profiling information, offering a deeper
Read More
